The Role of Modern Radiotherapy Technology in the Treatment of Esophageal Cancer

• Main Authors: Sung Ho Moon, Yang-Gun Suh
• Format: Article
• Language: English
• Published: Korean Society for Thoracic and Cardiovascular Surgery 2020-08-01
• Series: Korean Journal of Thoracic and Cardiovascular Surgery
• Subjects: esophageal neoplasms; radiotherapy; intensity-modulated radiotherapy; proton therapy

Radiation therapy (RT) has improved patient outcomes, but treatment-related complica-tion rates remain high. In the conventional 2-dimensional and 3-dimensional conformal RT (3D-CRT) era, there was little room for toxicity reduction because of the need to bal-ance the estimated toxicity to organs at risk (OARs), derived from dose-volume histogram data for organs including the lung, heart, spinal cord, and liver, with the planning target volume (PTV) dose. Intensity-modulated RT (IMRT) is an advanced form of conformal RT that utilizes computer-controlled linear accelerators to deliver precise radiation doses to the PTV. The dosimetric advantages of IMRT enable better sparing of normal tissues and OARs than is possible with 3D-CRT. A major breakthrough in the treatment of esophageal cancer (EC), whether early or locally advanced, is the use of proton beam therapy (PBT). Protons deposit their highest dose of radiation at the tumor, while leaving none behind; the resulting effective dose reduction to healthy tissues and OARs considerably reduces acute and delayed RT-related toxicity. In recent studies, PBT has been found to alleviate severe lymphopenia resulting from combined chemo-radiation, opening up the possibil-ity of reducing immune suppression, which might be associated with a poor prognosis in cases of locally advanced EC.